Fractyl Health, Inc. Common StockGUTSNASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 67% recommend buying.

Consensus Rating

Buy

3 analysts·Low coverage

67%

Rating Distribution

Strong Buy

00%

Buy

267%

Hold

133%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 959% higher.

Bear Case

$2.00

+323%

Consensus

$5.00

+959%

Bull Case

$8.00

+1594%

Price Range3 analysts

Low

Consensus

High

$2.00

$8.00

Current Target

Current Price

$0.47

Upside to Target

$4.53

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$-0.69(4 analysts)

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+79.54%

EPS—

FY2028

Rev+425.12%

EPS—

FY2029

Rev+115.37%

EPS—

Earnings Surprises

Beat rate:25%(2/8 quarters)

Avg surprise:-165.3%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Jan 29, 2026Morgan Stanley

Fractyl Health downgraded to Equal Weight from Overweight at Morgan Stanley

Target:$2.00

+241.9%from $0.58

Dec 19, 2025Canaccord Genuity

Canaccord Genuity Reiterates Buy Rating on Fractyl Health Inc (GUTS)

Target:$8.00

+254.0%from $2.26

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance